We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-2.54%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$49.4B
AUM Growth
-$1.83B
Cap. Flow
+$236M
Cap. Flow %
0.48%
Top 10 Hldgs %
23.11%
Holding
2,899
New
506
Increased
652
Reduced
806
Closed
772

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.93B
2
KVUE icon
Kenvue
KVUE
+$537M
3
HUM icon
Humana
HUM
+$477M
4
ABBV icon
AbbVie
ABBV
+$441M
5
MSFT icon
Microsoft
MSFT
+$384M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$747M
2
AAPL icon
Apple
AAPL
+$565M
3
ATVI
Activision Blizzard
ATVI
+$467M
4
MCK icon
McKesson
MCK
+$347M
5
INTC icon
Intel
INTC
+$300M

Sector Composition

Rank Sector Weight
1 Technology 19.79%
2 Healthcare 17.06%
3 Consumer Discretionary 12.96%
4 Consumer Staples 7.45%
5 Financials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WEAV icon
2026
Weave Communications
WEAV
$548M
$86.3K ﹤0.01%
10,593
-2,207
-17% -$22.4K
EOSE icon
2027
Eos Energy Enterprises
EOSE
$1.22B
$83.2K ﹤0.01%
+38,696
New +$116K
DMTK
2028
DELISTED
DermTech, Inc. Common Stock
DMTK
$82.9K ﹤0.01%
57,577
SPWRW
2029
CALL
SunPower Inc Warrants
SPWRW
$596K
$82K ﹤0.01%
39,830
-63,404
-61% -$20.6K
BEEM icon
2030
Beam Global
BEEM
$23.1M
$81.6K ﹤0.01%
+11,053
New +$103K
PLBY icon
2031
Playboy Inc
PLBY
$141M
$80.9K ﹤0.01%
101,081
+22,821
+29% +$32.7K
AUR icon
2032
Aurora
AUR
$12.2B
$80.7K ﹤0.01%
+34,333
New +$106K
DXLG icon
2033
Destination XL Group
DXLG
$34.3M
$76.3K ﹤0.01%
17,038
-2,405
-12% -$11.3K
PRQR icon
2034
ProQR Therapeutics
PRQR
$248M
$75K ﹤0.01%
57,717
-251,742
-81% -$396K
ATOM icon
2035
Atomera
ATOM
$187M
$74.7K ﹤0.01%
11,934
-20,983
-64% -$150K
AMD icon
2036
CALL
Advanced Micro Devices
AMD
$741B
$72K ﹤0.01%
700
-139,400
-100% -$15.1M
MYPS icon
2037
PLAYSTUDIOS Inc
MYPS
$76.9M
$71.9K ﹤0.01%
22,599
-36,289
-62% -$144K
BTAI icon
2038
BioXcel Therapeutics
BTAI
$26.1M
$71.4K ﹤0.01%
+1,763
New +$178K
DCTH icon
2039
Delcath Systems
DCTH
$399M
$70.3K ﹤0.01%
+17,364
New +$81.4K
DMAC icon
2040
DiaMedica Therapeutics
DMAC
$358M
$69K ﹤0.01%
+26,745
New +$85.9K
OTLY
2041
Oatly Group
OTLY
$473M
$68.2K ﹤0.01%
3,790
-24,705
-87% -$719K
LAB icon
2042
Standard BioTools
LAB
$311M
$68.1K ﹤0.01%
23,472
+7,300
+45% +$19.1K
LTRX icon
2043
Lantronix
LTRX
$238M
$67.6K ﹤0.01%
+15,195
New +$66.7K
BLDP
2044
Ballard Power Systems
BLDP
$808M
$67.2K ﹤0.01%
+18,300
New +$78.4K
XLV icon
2045
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$43.2B
$64.4K ﹤0.01%
500
-22,000
-98% -$2.92M
TUYA
2046
Tuya Inc
TUYA
$1.02B
$63.8K ﹤0.01%
41,162
NOTV
2047
DELISTED
Inotiv
NOTV
$63.2K ﹤0.01%
20,510
+1,196
+6% +$5.47K
NFGC
2048
New Found Gold
NFGC
$542M
$62K ﹤0.01%
14,865
+205
+1% +$927
BKCC
2049
DELISTED
BlackRock Capital Investment Corporation
BKCC
$61.9K ﹤0.01%
16,686
-3,500
-17% -$12.6K
LVO icon
2050
LiveOne
LVO
$64.8M
$61.4K ﹤0.01%
+6,391
New +$102K

Similar funds

Marshall Wace's Q3 2023 Portfolio in Review

As of Q3 2023, Marshall Wace held 2,899 positions worth $49.4B, down 3.6% from $51.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Marshall Wace's Q3 2023 filing shows 506 new, 652 increased, 806 reduced and 772 closed positions. Its largest new stake was Humana: 1,014,185 shares worth $493M. The largest sale was Amazon, an estimated $747M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q3 2023 buy was Humana: 1,014,185 shares worth $493M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q3 2023, an estimated $1.93B increase.
  • Marshall Wace's biggest Q3 2023 reduction was Amazon, cutting an estimated $747M.
  • Marshall Wace fully exited Johnson & Johnson in Q3 2023, selling an estimated $284M.
  • Marshall Wace's ten largest holdings make up 23% of its $49.4B portfolio in Q3 2023.
  • Marshall Wace opened 506 new positions and closed 772 in Q3 2023.
  • Marshall Wace's portfolio value fell 3.6% quarter-over-quarter to $49.4B.

Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.